Antibody Equipment-based

Updated as of March 08, 2021

results
# Rapid Antibody Test Kits Manufacturer IgM Clinical Sensitivity (95% CI) IgM Clinical Specificity (95% CI) IgG Clinical Sensitivity (95% CI) IgG Clinical Specificity (95% CI) OVERALL Date Performed
Day 8-14 Day 15-21 Day ≥ 22 TOTAL Day 8-14 Day 15-21 Day ≥ 22 TOTAL SENSITIVITY SPECIFICITY
1 MAGLUMI 2019-nCoV IgM/IgG (CLIA) Shenzhen New Industries Biomedical Engineering Co., Ltd. 96% (79.65 to 99.90) 92% (73.97 to 99.02) 92% (73.97 to 99.02) 93.33% (85.12 to 97.80) 92% (83.40 to 97.01) 76% (54.87 to 90.64) 72% (50.61 to 87.93) 80% (59.30 to 93.17) 76% (64.75 to 85.11) 97.33% (90.70 to 99.68) 84.67% (77.89 to 90.02) 92.67% (87.17 to 96.26) November 23-27, 2020
2 Elecsys Anti-SARS-CoV-2 (300 tests, for use in cobas e 801/200 tests, for use in cobas e 411, e 601, e 602) Roche Diagnostic GmbH 96% (80.36 to 99.90) 80% (59.30 to 93.17) 100% (86.28 to 100) 92% (83.40 to 97.01) 100% (95.20 to 100) 96% (80.36 to 99.90) 80% (59.30 to 93.17) 100% (86.28 to 100) 92% (83.40 to 97.01) 100% (95.20 to 100) 92% (83.40 to 97.01) 100% (95.20 to 100) November 25-27, 2020